Physical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung
The goal of this randomized controlled clinical trial is to test a 12-week physical activity telecoaching program for NSCLC patients after surgery. The main question it aims to answer is: What is the effectiveness and acceptability of a 12-week (semi)automated low-to-moderate intensity PA tele coaching program on physi
| Condition(s) | Non Small Cell Lung Cancer, Non-small Cell Carcinoma |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The goal of this randomized controlled clinical trial is to test a 12-week physical activity telecoaching program for NSCLC patients after surgery. The main question it aims to answer is: What is the effectiveness and acceptability of a 12-week (semi)automated low-to-moderate intensity PA tele coaching program on physical activity (mean steps per day) in resectable (stage I-IIIA) NSCLC patients after lung surgery, as compared to usual care? Patients with NSCLC will be enrolled in the study from 1 month postoperatively up to 1 year postoperatively. They will be randomized in either the intervention group or the control group. Patients randomized in the intervention group will be asked to enter a 12-week physical activity telecoaching program with the aim to enhance their physical activity. |
| Who can participate | Inclusion Criteria: * Resectable (I-IIIA) NSCLC patients who had lung resection surgery, one to twelve months before inclusion, with or without (neo-)adjuvant chemotherapy/radiotherapy/immunotherapy. * If patients received adjuvant chemotherapy/radiotherapy, the inclusion window is one months to twelve months after the end of adjuvant chemotherapy/radiotherapy. * If patients receive adjuvant immunotherapy after the end of adjuvant chemotherapy, patients can be included during the immunotherapy. * Adults (18+ year) * Patients who do not systematically perform structured exercise or are planned to do so. * Ability to give informed consent Exclusion Criteria: * Patients having progressive or recurrent lung cancer * Patients who had other malignancies in the last 2 years * Psychiatric disorder |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University Hospital, Ghent |
| Locations | Genk, Limburg, Belgium; Hasselt, Limburg, Belgium; Hasselt, Limburg, Belgium; Ghent, Oost-Vlaanderen, Belgium; Bruges, West-Vlaanderen, Belgium; Roeselare, West-Vlaanderen, Belgium |
| Start date | 2024-01-01 |
| NCT ID | NCT06057766 |
| Official listing | https://clinicaltrials.gov/study/NCT06057766 |